Over 600,000 people worldwide die from mosquito-borne malaria each year, with the majority of these deaths happening among ...

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...

People suffering from major depressive disorder (MDD) and treatment-resistant depression (TRD) often face challenging ...

SALT LAKE CITY, Utah. (Ivanhoe Newswire) - Chronic pain and treatment-resistant depression both impact millions of people. Both can be debilitating and both can leave people feeling hopeless, ...

Epilepsy is a chronic brain condition where nerve cells in the brain send incorrect signals causing seizures Heres how it ...

In a breakthrough study, researchers from the National University of Singapore (NUS) have developed a new way to deliver ...

Top-line data for its phase 2b trial studying GH001 is expected either in the fourth quarter of 2024 or the first quarter of ...

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression completed enrolment of the double-blind phase in Q3 2024Phase 1 ...

A mid-stage trial of oral ketamine tablets has shown promising results in treatment-resistant depression (TRD), setting ... quarter of the year puts the drug on course to achieve sales above ...